Empty Capsules Market is anticipated to rise at a high CAGR of 8% from 2022 to 2026

[204 Pages Report] Empty capsules are witnessing an adoption upsurge, owing to numerous factors such as limited number of competitors, growing demand from the pharmaceutical sector, standard margin level, and potential opportunities in vegan gelatin-based capsules. Further, faster uptake by the FDA and focus of market players on ramping up production capacity are key factors shaping the growth of the empty capsules market.

Empty capsule manufacturers are progressively targeting specialty markets such as contract manufacturers, generic manufacturers, and pediatric drug manufactures. Increasing penetration of low-cost manufacturers in various countries, and supply contracts of life-saving essential drugs, primarily in developing and emerging countries, are further driving the empty capsules market.

Empty Capsules Market Size (2022) US$ 2.1 Bn
Predicted Revenue Total (2026) US$ 2.9 Bn
Forecasted Growth Rate (2022-2026) 8%
North America Market Share 38.3%

The global empty capsules market is estimated to be valued at US$ 1.9 Bn in 2022, with the market expected to exhibit a CAGR of 8% during the forecast period (2022-2030). The coronavirus (COVID-19) pandemic that has so far claimed the lives of over 200,000 people and infected over 3 million, has forced several countries to declare nationwide lockdowns. This has disturbed supply chains in the empty capsules market, due to logistics paralysis. As such, the market is expected to witness a gradual decline in in 2022.

“Lower labour cost and abundant availability of raw materials are among the key factors driving the empty capsules market in Asia Pacific excluding Japan (APEJ) and Western Europe. In addition, favorable regulatory ecosystem to establish empty capsule manufacturing businesses and lower taxation policies are propelling market growth in APAC.”

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-782

Key Takeaways of Empty Capsules Market Study

  • Greater focus on relieving pressure of supply chain due to demand gap is being tackled by ramping up production capacity; up-scaling is the fundamental strategy outlined for meeting demand in the empty capsules market.
  • Vegetable capsules are the latest innovation and are expected to replace gelatin-based variants. Recently, hard gelatin manufacturers have begun increasing the production of vegetarian capsules at scale.
  • South and East Asian pharmaceutical markets are expected to grow at twice the global average in terms of value, owing to population growth, rising incomes, and improved access to healthcare.
  • The empty capsules market in China is anticipated to exhibit the fastest growth, where per capita spending is anticipated to increase by over 70% in the coming five years.
  • High upfront costs and lower margin levels in empty capsules have resulted in 10%-20% price hike in finished products, registering lower sales for animal-based gelatin products in the recent past.
  • India, with almost 40% growth, is offering value-capture opportunities, owing to good patient recruitment, acceptable quality of services, reasonable cost-quality ratio, existence of regulatory agencies, high standards of care, larger population base, and low cost of labour.
  • Companies manufacturing halal capsules are obtaining halal certification from the Islamic Food and Nutrition Council of America (IFANCA) to capture market shares in Muslim-dominated countries.
  • The empty capsules market is consolidated, with leading manufacturers holding around 70% revenue share. Further, growing prominence of CMOs and large-scale gelatin manufacturers is anticipated to boost the growth engine.
  • Higher volume handling by key players in comparison with local manufacturers, and higher production capabilities and price advantages over non-standard manufacturers, are expected to generate significant revenue pockets.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-782

Key Players Focus on Capacity Expansion, Strategic Acquisitions, and Joint Ventures to Widen Regional Presence

Leading players 

  • ACG Worldwide,
  • Capsugel,
  • Qualicaps, Inc.,
  • Bright Pharma Caps, Inc., and Roxlor LLC,

are concentrating on business expansion through mergers, joint ventures, distribution agreements, and capturing untapped market potential.

  • For example, in 2015, Capsugel increased the production of vegetarian-based capsules by investing US$ 25 Mn across its manufacturing sites.
  • Empty capsule manufacturers are generating high returns from nutraceutical and pharmaceutical industries by supplying non-animal or vegetarian empty capsules, with effective physical properties such as reduced moisture content, best suited for nutrient supplements and hygroscopic drugs.
  • In similar context, empty capsule manufacturers are boosting substantial sales revenue from nutraceutical manufacturers by supplying vegetarian-based empty capsules coupled with fluid filling technology.
  • Top manufacturers of hard gelatin capsules are expanding their production facilities through acquisitions.
  • For instance, Qualicaps completed the acquisition of Genix Industria Farmaceutica Ltd., one of Brazil’s top hard empty capsule manufacturers. The acquisition permits the manufacturer to establish its operating sites in the U.S., Canada, Spain, Japan, and Romania.
    • CapsCanada Corporation also acquired the assets of two additional gelatin manufacturing facilities, and this significant acquisition further merged with the manufacturer’s vertically-integrated production plants, with a total of four (bovine) other gelatin manufacturing facilities.

Additionally, current acquisitions are focused on capacity expansion and manufacturing capabilities of existing empty capsules players to gain market share.

More Valuable Insights on Empty Capsules Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2029. The global empty capsules market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on the market on the basis of by product type (gelatin (hard)-based capsules and vegetarian-based capsules), raw material (type-A (pork skin), type-B gelatin (animal bones & calf skin), fish bone gelatin, hydroxy propyl methyl cellulose (HPMC), starch materials, and pullulan.), capsule size (size “000” capsules, size “00” capsules, size “0” capsules, size “1” capsules, size “2” capsules, size “3” capsules, size “4” capsules, and size “5” capsules.), route of administration (oral administration and inhalation administration.), and end user (pharmaceutical companies, cosmetic & nutraceutical companies and clinical research organizations (CROs), across seven major regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/782

Key Segments of Empty Capsules Industry Survey Empty Capsules Market by Capsule Size:

  • Size “000” Empty Capsules
  • Size “00” Empty Capsules
  • Size “0” Empty Capsules
  • Size “1” Empty Capsules
  • Size “2” Empty Capsules
  • Size “3” Empty Capsules
  • Size “4” Empty Capsules
  • Size “5” Empty Capsules

Empty Capsules Market by Product Type:

  • Gelatin (Hard)-based Capsules
  • Vegetarian-based Capsules

Empty Capsules Market by Route of Administration:

  • Empty Capsules for Oral Administration
  • Empty Capsules for Inhalation

Empty Capsules Market by Raw Material:

  • Contract Type-A (Pork Skin) Empty Capsules
  • Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
  • Fish Bone Gelatin Empty Capsules
  • Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
  • Starch Material Empty Capsules
  • Empty Pullulan Capsules

Empty Capsules Market by End User:

  • Empty Capsules for Pharmaceutical Companies
  • Empty Capsules for Cosmetic & Nutraceutical Companies
  • Empty Capsules for Clinical Research Organizations (CROS)

Empty Capsules Market by Region:

  • North America Empty Capsules Market
  • Latin America Empty Capsules Market
  • Europe Empty Capsules Market
  • East Asia Empty Capsules Market
  • South Asia & Pacific Empty Capsules Market
  • Middle East & Africa (MEA) Empty Capsules Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Europe Viscosupplementation Market is projected to grow at 9.37% CAGR through 2032

Growing prevalence of osteoarthritis, strong healthcare infrastructure and well established reimbursements are soaring the demand for viscosupplementation market. The Europe viscosupplementation market has been segmented by product type, end user and region.

Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-EU-1383

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1383

Key Players in Europe Viscosupplementation Market

  • Anika Therapeutics Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings
  • Meda AB
  • Ferring B.V
  • Fidia Pharmaceutici S.p.A
  • Bioventus LLC.

We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market.  Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1383

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

 Key Regions/Countries

  • Western Europe
    • K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe

Eastern Europe

  • Russia
  • Rest of Eastern Europe

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Contrast Media Injectors Market Analysis Report by Marketing Strategy, Promotions, New Product Launches and Emerging Trends by 2030

[269 pages Report] FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Data Points Market Insights
Market Value 2021 USD 1.4 Bn
Market Value 2022 USD 1.5 Bn
Market Value 2030 USD 2.4 Bn
CAGR 2022-2030 6.2%
Key Players The key players are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,
Share of Top 5 Countries 58.1%
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-823
Key Takeaways of Contrast Media Injectors Market Study 

  • North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
  • Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
  • AI is expected to speed up the process of injecting contrast media in the forecast period
  • Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

“Development of advanced contrast media injectors including automated and IT/software technology at low cost is the major focus area of the manufacturers, which provides a competitive advantage” says an FMI Analyst.

New Product Launches and Approval – The Ongoing TrendThe market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

  • In Apr 2022, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
  • In Nov 2021, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
  • In Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-823

Contrast Media Injectors Market by CategoryBy Product:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Automated Breast Ultrasound Systems Market Comprehensive Research Study and Strong Growth in Future 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

  • Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
  • The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
  • Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
  • Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
  • India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
  • Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-606

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan,  and Middle East & Africa)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-606

Key Segments Covered

By End User

  • Hospitals
  • Diagnostic Imaging Laboratories
  •  America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Western Europe
    • EU-5
    • BENELUX (Belgium, Netherlands, Luxembourg)
    • NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
    • Rest of Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
  • Japan
  • APEJ (Asia Pacific excluding Japan)
    • China
    • India
    • ASEAN Countries
    • Australia & New Zealand
    • Rest of APEJ
  • MEA
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Automated CPR Devices Market Future Scenarios, Growth and Analytical Insights – 2031

The demand for automated CPR devices has been increasing significantly with rising prevalence of sudden cardiac arrest across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated CPR devices market is slated to grow at approximately 13% CAGR throughout the forecast period from 2021 to 2031.

The market is anticipated to grow significantly over the forthcoming decade, as majority of coronary and intensive care units are inclining towards automated CPR devices for its high effectiveness.

Major progress has been witnessed with 3D automatic CPR devices, especially when normal CPR device coupled with torso restraints providing vertical compression and high quality resuscitation.

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

 “Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-720

Key Takeaways from FMI’s Automated CPR Devices Market Study

  • Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
  • The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
  • Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
  • China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
  • India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

Competitive Landscape

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-720

Key Segments Covered

By Power Source

  • Pneumatically Driven CPR Devices
  • Battery Driven CPR Devices
  • Mechanically Actuated And Battery Driven CPR Device

By Device Type

  • Piston Devices
  • Load Distribution Devices
  • 3D Compression Devices

By End User

  • EMS
  • Hospitals
  • Ambulances
  • Coronary & Intensive Care Units
  • Cardiac Catheterization Labs
  • Air Med-Evac Units
  • EMT Rescue Units
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Orthopaedic Prosthetics Market will witness a CAGR of over 4.5% through 2030

[250 Pages Report] A recent market study published by Future Market Insights on the orthopaedic prosthetics market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, the growth prospects of the market are obtained with utmost precision.

Orthopaedic Prosthetics Market Outlook & Key Findings
  • The global Orthopaedic Prosthetics market will witness a CAGR of over 4.5% through 2030
  • Lower extremity prosthetics remain the largest category, accounting for nearly two-thirds market share
  • 3D printed prosthetics will remain a key growth driver during the forecast period
  • Asia Pacific will witness the highest growth rate during the assessment period
  • North America and Europe will remain two big markets, accounting for over 50% of market share

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1443

Key Players :

  • Exatech Inc.
  • Howard Orthopaedics Inc.
  • Hanger Inc.
  • Wishbone Medical
  • Pega Medical
  • OrthoPediatrics
  • Arthrex
  • Touch Bionics Inc.
  • Advanced Arm Dynamics
  • Medtronic Spinal
  • Integra Lifesciences
  • Globus Medical
  • DJO Global

Orthopaedic Prosthetics Market: Segmentation

The global orthopaedic prosthetics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

  • Upper Extremity Prosthetics
    • Hand Prosthetics
    • Elbow Prosthetics
    • Shoulder Prosthetics
  • Lower Extremity Prosthetics
    • Foot & Ankle Prosthetics
    • Knee Prosthetics
    • Hip Prosthetics
  • Liners
  • Sockets
  • Modular Components

Technology

  • Conventional
  • Electric Powered
  • Hybrid Orthopaedic Prosthetics

End User

  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Center
  • Others

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-1443

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the orthopaedic prosthetics market, which includes a snapshot of key findings and statistics. It also includes drivers and trends pertaining to the market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the orthopaedic prosthetics market in this chapter, which will help them understand the basics of the market. Along with this, comprehensive information pertaining to orthopaedic prosthetics and their properties are provided in this section. This section also highlights the inclusions and exclusions, which help the reader understand the scope of the market report.

Chapter 03 – Market Background

This section gives information about drivers and restraints of the orthopaedic prosthetics market. This section also includes various opportunities pertaining to the market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PESTLE analysis, Porter’s Five Forces Model, and regulatory scenario of the market.

Chapter 05 – Global Orthopaedic Prosthetics Market Demand (size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

This section explains the global market value analysis and forecast for the market during the forecast period (2020-2030). It includes a detailed analysis of the historical orthopaedic prosthetics market, along with an opportunity analysis for the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Orthopaedic Prosthetics Market Analysis 2015-2019 and Forecast 2020-2030, by Product

Based on product, the orthopaedic prosthetics market is broadly segmented into upper extremity prosthetics, lower extremity prosthetics, liners, sockets and modular components. In this chapter, readers can find information about the key trends and developments in the market and market attractiveness based on product.

Chapter 07 – Global Orthopaedic Prosthetics Market Analysis 2015-2019 and Forecast 2020-2030, by Technology

Based on technology, the market is segmented into conventional, electric powered, and hybrid orthopaedic prosthetics. In this chapter, readers can understand the market attractiveness based on technology.

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals, independent catheterization centers, and healthcare clinics will continue rising. Spurred by this, the global transradial closure devices market is set to grow by 6.5% CAGR during the forecast period from the year 2020 to 2030.

In Vitro Fertilization Banking Services Market – The in vitro fertilization banking services market, despite undergoing a temporary period of lull due to COVID-19 outbreak, is likely to have an impressive growth trajectory between 2020 and 2030.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Surface Plasmon Resonance Market Comprehensive Research Study and Strong Growth in Future 2029

The global surface plasmon resonance market is estimated to be valued at US$ 910.4 Mn in 2022 and is expected to reach US$ 1.5 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-962

Key Takeaways of Surface Plasmon Resonance Market Study

  • The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
  • Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
  • Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-962

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

SURFACE PLASMON RESONANCE MARKET TAXONOMY

The global surface plasmon resonance market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Imaging Systems
  • Sensor Systems
  • Reagents

Application

  • Drug Discovery
  • Material Science
  • Biosensors

End User

  • Academic & Research Institutes
  • Food & Beverage Industry
  • Biopharmaceutical Companies
  • CROs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Cardiac Assist Devices Market is Expected to Generate Huge Profits by 2031

Future Market Insight’s (FMI’s) latest study published on the Cardiac Assist Devices market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Cardiac Assist Devices market.As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Cardiac Assist Devices market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Cardiac Assist Devices market.

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Cardiac Assist Devices Market over the Assessment Period (2021-2031)

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-467

Advent of Telehealth and Virtual Care to Create Tailwind for the Cardiac Assist Devices Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Cardiac Assist Devices market.

Key Cardiac Assist Devices Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Cardiac Assist Devices market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-467

Report Benefits & Key Questions Answered

Cardiac Assist Devices Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Cardiac Assist Devices market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Cardiac Assist Devices Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Cardiac Assist Devices market. As per the survey, Cardiac Assist Devices sales will project steady growth over the forecast period.

Cardiac Assist Devices Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Cardiac Assist Devices market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Cardiac Assist Devices Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Cardiac Assist Devices Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Get In Touch With Our Team For 20% Flat Discount : https://www.futuremarketinsights.com/ask-question/rep-gb-467 

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Cardiac Assist Devices market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Cardiac Assist Devices market.

Some of the prominent market players are profiled by FMI

  • Terumo Corporation
  • Medtronic PLC
  • Abbott Laboratories
  • Abiomed Inc.
  • Teleflex Incorporated
  • Maquet GmbH
  • BerlinHeart GmbH
  • Others

Cardiac Assist Devices Demand Analysis by Category
By Product Type:

  • Ventricular Assist Devices (VAD)
  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BIVAD)
  • External Ventricular Assist Devices
  • Intra-Aortic Balloon Pump

By Modality Type:

  • Transcutaneous
  • Implantable

By End-User:

  • Hospital
  • Ambulatory Surgical Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Hyaluronic Acid Products Market Future Analysis, Demand by Regions and Opportunities with Challenges 2030

[284 Pages Report] Hyaluronic acid products have been gaining the momentum backed by massive use in therapies intended at the treatment of osteoarthritis, vesicoureteral reflux (VUR), and dry eye diseases, besides diverse aesthetic applications. Future Market Insights (FMI) in a new study has forecast the global market for hyaluronic acid products to surpass US$ 2.7 Bn by 2021.

As a result, the demand of minimally invasive treatment for diseases such as osteoarthritis and VUR stemmed. Manufacturers are introducing advanced intra-articular hyaluronic acid injections (IAHA) injections for the minimal invasive pain management with minimal pain, short recovery time and shorter hospital stay period.

The rising demand of the minimally invasive treatment for the pain management of osteoarthritis and other chronic ailments have pushed the key players to introduce innovative hyaluronic acid products into the market. The conventional treatment regime for chronic diseases was often invasive, involving certain amount of risk for patients with medical-comorbidities. These treatment methods often resulted in long hospital stays.

FMI has forecast dermal fillers to remain key application segment, accounting for over 35% of sales in 2021. The dermatological application of hyaluronic acid also has seen surge with the introduction of advanced dermal fillers, masks, and serums for application in restorative therapy and wrinkle augmentations.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-486

Major Key Players:

  • Anika Therapeutics, Inc.
  • Fidia Farmaceutici S.p.A.
  • Sanofi
  • Ferring B.V.
  • Viatris Inc.
  • Croma-Pharma
  • Seikagaku Corporation
  • Zimmer Biomet
  • Lifecore Biomedical, LLC
  • LG Chem
  • Bioventus LLC
  • Smith & Nephew plc
  • Shanghai Jingfeng Pharmaceutical Co., Ltd.
  • Nestle (Galderma)
  • Bausch Health Companies Inc. Companies Inc. (Salix Pharmaceuticals, Inc.)
  • Allergan Plc.

The global hyaluronic acid products market is set to expand its scope in the forecast period, as a result of rising prevalence of chronic diseases and expanding geriatric population. In addition to this, the rising demand for minimally invasive therapies and advancing aesthetic procedures and products are propelling the growth of the market.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-486

Key Takeaways from Hyaluronic Acid Products Market Study

  • The hyaluronic acid products market will expand at a CAGR of 6.1% between 2020 and 2030
  • The U.S. will emerge as one of the leading markets, accounting for over 73% of sales in North America
  • The U.K. will remain one of the key markets within Europe, registering 7.7% Y-o-Y growth in 2021
  • The demand for Germany and France will continue rising at a positive rate
  • Japan will emerge as a leading market in East Asia, followed by China and South Korea

Who is winning?

Manufacturers in the hyaluronic acid products market are focusing on advanced IAHA injections, dermal filler, and other products. The delivery of hyaluronic acid to the target site has been made effective, precise, and minimally invasive. This is intended at ensuring more effective pain management for various chronic and inflammatory diseases such as osteoarthritis. Many manufacturers are focused on developing advanced, effective and affordable IAHA injections that come with advanced targeted delivery and minimal invasiveness.

For instance, Synvisc by Sanofi is effective for osteoarthritis pain. The advanced range of dermal filler launched by Galderma of Nestlé, named Restylane covers a wide spectrum dermal application for volume restorative therapy and Restylane Lyft is indicated for the wrinkle augmentation of the backside of the hand.

Valuable Insights into Hyaluronic Acid Products Market

Future Market Insights, in its new report, provides an unbiased analysis of the hyaluronic acid products market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2030. The study divulges compelling insights into the hyaluronic acid products market based on product type (single cycle injection, three cycle injection, five cycle injection), application (osteoarthritis, ophthalmic, dermal fillers, and vesicoureteral reflux), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and specialty clinics). Regionally the market covers North America, Europe, Latin America, East Asia, South Asia, Oceania, and the Middle East and Africa.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-486

Hyaluronic Acid Products Market by Category

Product

  • Single Cycle Injection Products
  • Three Cycle Injection Products
  • Five Cycle Injection Products

Application

  • Osteoarthritis
  • Ophthalmic
  • Dermal Fillers
  • Vesicoureteral Reflux

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Speciality Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Caprolactam Favoring Growth of Ammonium Phosphate Market is projected to be valued at US$ 15.0 billion in 2022

Asia Pacific is expected to possess 40% of market share for global ammonium sulphates market in the assessment period 2022-2032. Europe is expected to procure 35% of market share for ammonium sulphates market in the forecast period 2022-2032

NEWARK, Del., Sept. 6, 2022 /PRNewswire/ — A recently published study by FMI expects the global ammonium sulphate market to augment at a 7.5% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 6.18 Billion is expected for the market. The demand for ammonium phosphate is growing owing to its increasing usage in the agricultural sector. Moreover, application of ammonium phosphate has found a place in the biopharmaceutical and cake and confectionery industries too. This, in turn, is positively influencing the growth of ammonium phosphate market.

From 2017 to 2021, the industry experienced noteworthy growth, registering a value CAGR of 5% and closing at US$ 2.79 Billion. The COVID-19 pandemic affected the demand for ammonium phosphate positively as the same is widely used in the production of disinfectants and surface cleaners. In addition, modification of ammonium phosphate for maximizing the use of the same is creating opportunities for the market.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-we-1236

The increasing use of ammonium phosphate in Europe for water retention purposes and for agriculture in Asia Pacific is further contributing to the market growth. Furthermore, the use of ammonium phosphate for wood preservation and soil retention is favoring the growth of the market. In the upcoming years, the dependency on ammonium phosphate is expected to increase by end user industries owing to its multi-purpose use.

Key Takeaways from the Market Study

  • By production process, caprolactam is expected to hold 40% market share for ammonium sulphate in 2022.
  • North America is expected to hold 45% for ammonium phosphate market in 2022.
  • Asia Pacific is expected to possess 40% of market share for global ammonium sulphates market in the assessment period 2022-2032.
  • Europe is expected to procure 35% of market share for ammonium sulphates market in the forecast period 2022-2032.

“The increasing use of ammonium phosphate in end user industries especially in the agricultural sector by different geographical locations is increasing the demand for the same.” says an FMI analyst

Market Competition

Key players in the ammonium sulphate market are Koninklijke DSM N.V. (Fibrant), JSC KuibyshevAzot, UBE Industries Ltd, Toray Industries Inc., China Petrochemical Development Corporation, China Petroleum & Chemical Corporation (Sinopec Corp.), JSC “Grodno Azot”, Grupa Azoty, Domo Chemicals, Gujarat State Fertilizers & Chemicals Ltd, Sumitomo Chemical, Evonik Industries AG

  • In August 2022, JSC “Grodno Azot” announced that it will be partially limiting the production of nitrogen fertilizer due to the increase in prices of natural gas.
  • DOMO Chemicals, a key player in the ammonium sulphate market is focusing on producing the same sustainable and reducing their overall carbon footprint.

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global ammonium phosphate market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Production (Process Caprolactam, Coke Oven Gas, Gypsum, and Neutralization & Others) across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About the Chemical and Material Division at FMI

The chemicals & materials team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-we-1236

Key Segments Profiled in the Ammonium Sulphate Market Industry Survey

Ammonium Sulphate by Production Process:

  • Ammonium Sulphate for Caprolactam
  • Ammonium Sulphate for Coke Oven Gas
  • Ammonium Sulphate for Gypsum
  • Ammonium Sulphate for Neutralization & Others

Ammonium Sulphate by Region:

  • North America Ammonium Sulphate Market
  • Latin America Ammonium Sulphate Market
  • Europe Ammonium Sulphate Market
  • Asia Pacific Ammonium Sulphate Market
  • Middle East & Africa Ammonium Sulphate Market

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs